Related Experiment Videos
Pleural effusions and pneumothoraces in AIDS
1Division of Pulmonary and Critical Care Medicine and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA. afessa.bekele@mayo.edu
Current Opinion in Pulmonary Medicine
|July 27, 2001
Summary
Pneumothorax and pleural effusions are serious conditions in HIV patients, often linked to infections like Pneumocystis pneumonia or cancers such as Kaposi sarcoma. Management requires intensive care and focuses on palliation due to poor prognosis.
Area of Science:
- Pulmonology
- Infectious Diseases
- Oncology
Background:
- Pneumothorax affects 1-2% of hospitalized HIV patients, carrying a 34% mortality rate.
- Pleural effusion is observed in 7-27% of hospitalized HIV patients.
- HIV-associated lung conditions significantly impact patient morbidity and mortality.
Purpose of the Study:
- To summarize the incidence, risk factors, and management of pneumothorax in HIV patients.
- To outline the common causes and clinical significance of pleural effusions in HIV infection.
- To discuss the poor prognosis and palliative care goals for specific HIV-related pleural diseases.
Main Methods:
- Review of clinical data and literature concerning pneumothorax and pleural effusions in HIV.
- Identification of risk factors, including Pneumocystis carinii pneumonia and specific malignancies.
- Analysis of treatment modalities and prognostic indicators for these conditions.
Main Results:
- Spontaneous pneumothorax in HIV is associated with Pneumocystis pneumonia and radiographic findings.
- Common causes of pleural effusion in HIV include parapneumonic effusions, tuberculosis, and Kaposi sarcoma.
- Pulmonary Kaposi sarcoma and primary effusion lymphoma (associated with human herpesvirus 8) have a poor prognosis.
Conclusions:
- Spontaneous pneumothorax in HIV patients often necessitates invasive management like tube thoracostomy or surgery.
- Pleural effusions in HIV are multifactorial, with malignancies playing a significant role.
- Palliative care is crucial for patients with advanced HIV-related pleural Kaposi sarcoma and lymphoma.